| 臺大學術典藏 |
2019-10-23T13:07:21Z |
Prognostic value of the mitogen response in the interferon-γ release assay in patients with culture-confirmed tuberculosis
|
CHONG-JEN YU;JANN-YUAN WANG;CHUN-TA HUANG;MENG-RUI LEE;SHENG-YUAN RUAN;Tsai, Yi Ju; SHENG-YUAN RUAN; Tsai, Yi Ju; MENG-RUI LEE; CHUN-TA HUANG; JANN-YUAN WANG; CHONG-JEN YU |
| 臺大學術典藏 |
2019-03-04T08:06:47Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
|
Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T08:06:47Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
|
Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-01-01 |
Intensive care unit admission and survival in stage IV cancer patients with septic shock: A population-based cohort study
|
CHAO-LUN LAI; MENG-RUI LEE; Chan, K. Arnold; CHAO-LUN LAI;MENG-RUI LEE;Chan, K. Arnold |
| 臺大學術典藏 |
2019-01-01 |
Intensive care unit admission and survival in stage IV cancer patients with septic shock: A population-based cohort study
|
CHAO-LUN LAI; MENG-RUI LEE; Chan, K. Arnold; CHAO-LUN LAI;MENG-RUI LEE;Chan, K. Arnold |
| 臺大學術典藏 |
2019 |
CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status
|
Chang L.-Y.; Chang C.-H.; MENG-RUI LEE; Chuang Y.-C.; Sun H.-Y.; Wang J.-T.; Wang J.-Y. |
| 臺大學術典藏 |
2018-09-10T18:07:07Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang, S.-K. and Lee, M.-R. and Liao, W.-Y. and Ho, C.-C. and Ko, J.-C. and Shih, J.-Y.; MENG RUI LEE; Wei-Yu Liao; Chao-Chi Ho; Jin-Yuan Shih; JEN-CHUNG KO; SHENG-KAI LIANG |
| 臺大學術典藏 |
2018-09-10T18:06:04Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang, S.-K. and Hsieh, M.-S. and Lee, M.-R. and Keng, L.-T. and Ko, J.-C. and Shih, J.-Y.; MENG-RUI LEE; KENG LI-TA; JEN-CHUNG KO; SHENG-KAI LIANG; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:05:30Z |
Acute biliary events during anti-tuberculosis treatment: hospital case series and a nationwide cohort study
|
Lih-Yu Chang and Chih-Hsin Lee and Chia-Hao Chang and Ming-Chia Lee and Meng-Rui Lee and Jann-Yuan Wang and Li-Na Lee; LI-NA LEE; MENG-RUI LEE; JANN-YUAN WANG; LIH-YU CHANG |
| 臺大學術典藏 |
2018-09-10T18:05:19Z |
Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease
|
Goletti, D. and Lee, M.-R. and Wang, J.-Y. and Walter, N. and Ottenhoff, T.H.; MENG-RUI LEE; JANN-YUAN WANG |
